Compound 1113
Identifiers
- Canonical SMILES:
CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cn1)-c1nnn[nH]1)c1cc(Cl)cc(Cl)c1
- IUPAC name:
4-[(5S,9R)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-7-[5-(2H-tetrazol-5-yl)pyridin-2-yl]-1,3,7-triazaspiro[4.4]nonan-9-yl]benzonitrile
- InChi:
InChI=1S/C26H19Cl2N9O2/c1-35-25(39)37(20-9-18(27)8-19(28)10-20)24(38)26(35)14-36(13-21(26)16-4-2-15(11-29)3-5-16)22-7-6-17(12-30-22)23-31-33-34-32-23/h2-10,12,21H,13-14H2,1H3,(H,31,32,33,34)/t21-,26+/m0/s1
- InChiKey:
PMZWNDSIHRPMEQ-HFZDXXHNSA-N
External links
![]() 46224088 |
![]() CHEMBL1098727 |
![]() 24677769 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 8.74 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 559.10 g/mol | |||
HBA | 11 | |||
HBD | 1 | |||
HBA + HBD | 12 | |||
AlogP | 2.84 | |||
TPSA | 135.00 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5781 | Degarelix | DB06699 | |
0.5092 | SB-705498 | DB11883 | |
0.4876 | ALK-4290 | DB15269 | |
0.4716 | BMS-564929 | DB07286 | |
0.4685 | Olcegepant | DB04869 | |
0.4678 | Acyline | DB11906 | |
0.4602 | Telinavir | DB12178 | |
0.4593 | Ivosidenib | DB14568 | |
0.4591 | Bremelanotide | DB11653 | |
0.4557 | Cetrorelix | DB00050 | |
0.4555 | Ubrogepant | DB15328 | |
0.4549 | LTX-109 | DB12711 | |
0.4549 | Triptorelin | DB06825 | |
0.4549 | Deslorelin | DB11510 | |
0.4549 | Leuprolide | DB00007 |